SPECT and PET imaging of the dopaminergic system in Parkinson's disease

@article{Bruecke2000SPECTAP,
  title={SPECT and PET imaging of the dopaminergic system in Parkinson's disease},
  author={Thomas Bruecke and S. Djamshidian and G. Bencsits and W. Pirker and S. Asenbaum and I. Podreka},
  journal={Journal of Neurology},
  year={2000},
  volume={247},
  pages={IV2-IV7}
}
Summary This paper gives an overview of the clinical importance of SPECT and PET imaging of the dopaminergic system in the differential diagnosis and for the determination of the progression rate of Parkinson's disease (PD). D2 receptor imaging can help to differentiate multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) from PD. In patients treated with neuroleptics it is possible to determine the rate of striatal D2 receptor blocking using this technique. This occupancy… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 39 CITATIONS

The significance of neuronal lateralisation in Parkinson’s disease

  • Journal of Neural Transmission
  • 2012
VIEW 4 EXCERPTS
CITES RESULTS & BACKGROUND
HIGHLY INFLUENCED

Computer-aided differential diagnosis in movement disorders using MRI morphometry

  • Medical Imaging: Computer-Aided Diagnosis
  • 2007
VIEW 9 EXCERPTS
CITES METHODS
HIGHLY INFLUENCED

Possible impact of dopamine SPECT on decision-making for drug treatment in Parkinsonian syndrome

  • Journal of Neural Transmission
  • 2005
VIEW 5 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 32 REFERENCES

Dopamine D2 receptor imaging with SPECT. Studies in different neuropsychiatric disorders

T Brücke, I Podreka, +5 authors L Deecke
  • J Cereb Blood Flow Metab
  • 1991
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Relative rates of progression of early Parkinson’s disease patients started on either a dopamine agonist (ropinirole) or levodopa: 2-year and 5-year followup [18F]-Dopa PET findings

DJ Brooks, JS Rakshi, +4 authors DL Bailey
  • [abstract]. Neurology
  • 2000
VIEW 1 EXCERPT

ß - CIT / SPECT assessment of progression of Parkinson ’ s disease in subjects participating in the CALM - PD study [ abstract ]

KL Marek
  • 2000

Comparison of [123I]ß-CIT and SPECT in lower body parkinsonism and Parkinson’s disease

G Bencsits, W Pirker, +5 authors T Brücke
  • Mov Dis13,
  • 1998
VIEW 1 EXCERPT

Positron emission tomography studies in movement disorders

DJ Brooks
  • Neurosurg Clin N Am
  • 1998
VIEW 2 EXCERPTS